Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

AOP Orphan Announces Leadership Changes to Advance Long Term Strategic Direction

27. 8. 2021

AOP Orphan Pharmaceuticals presents latest analysis on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia vera at the prestigious European Hematology Association (EHA) Annual Meeting 2020

1. 7. 2021

Silver Export Award presented to AOP Orphan

9. 4. 2021

AOP Orphan reports full validity of arbitral award against PharmaEssentia

25. 3. 2021

Health Europe: AOP Orphan a European pioneer in the field of rare and complex diseases

18. 3. 2021

BESREMi® (Ropeginterferon alfa-2b) deemed safe and efficacious by the US FDA

15. 3. 2021